TUL participates in Pharmtech&Ingredients 2025 exhibition in Russia

TUL has been ranked among the top 20 ESG competitive companies among Chinese pharmaceutical listed companies in 2025, and has been selected as one of the top 20 most competitive companies

TUL selected as the "2025 Huaxia ESG Dandelion Typical Case"

TUL participated in the 27th Academic Conference of diabetes Branch of Chinese Medical Association

United Laboratories animal healthcare launches seven new pet products

The United Laboratories animal healthcare and Zhongrui Supply Chain reach strategic partnership for pet medicine

TUL has been listed as one of the top 40 leading innovative drug companies in China's overseas market in 2025

Zhuhai United Laboratories Animal Healthcare Co., Ltd.'s six raw material drug production lines have passed the on-site acceptance of animal medicine GMP

Zhuhai United Laboratories Co., Ltd.'s Quality Inspection Center has passed the CNAS US Pharmacopeia and UK Pharmacopeia Testing Capability Expansion Review